<DOC>
	<DOCNO>NCT01433237</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study biomarkers sample patient rhabdomyosarcoma .</brief_summary>
	<brief_title>Studying Biomarkers Samples From Patients With Rhabdomyosarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether circulate muscle-specific microRNAs , especially serum miR-206 , potential biomarkers rhabdomyosarcoma ( RMS ) . OUTLINE : Archived serum sample analyze miR-206 expression . PROJECTED ACCRUAL : A total 15 sample patient alveolar rhabdomyosarcoma ( RMS ) , 15 patient embryonal RMS , 10 patient without RMS accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Serum specimens rhabdomyosarcoma ( RMS ) , embryonal RMS , nonRMS available Soft Tissue Sarcoma committee Children 's Oncology Group PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>embryonal childhood rhabdomyosarcoma</keyword>
	<keyword>adult rhabdomyosarcoma</keyword>
	<keyword>alveolar childhood rhabdomyosarcoma</keyword>
	<keyword>adult soft tissue sarcoma</keyword>
	<keyword>childhood rhabdomyosarcoma</keyword>
</DOC>